- After less than two years in the position
- Praise, thanks and good wishes for Stanleick
- Marla Beck taking over temporarily
- Search for a successor
- Stanleick said 64 words
(exechange) — Long Beach, California, November 13, 2023 — Andrew Stanleick, chief executive of BeautyHealth, leaves his position. As announced by BeautyHealth Co. in a news release and in a regulatory filing published on Monday, November 13, 2023, Andrew Stanleick leaves his post as chief executive officer at the company best known for its Hydrafacial brand, after less than two years in the role, effective November 19, 2023.
Generally speaking, it raises questions when a CEO leaves his post at short notice and after a short tenure.
BeautyHealth will undertake a search for a successor.
Andrew Stanleick’s duties as CEO will be taken over temporarily by Marla Beck, a former chief executive officer at Bluemercury, as Interim Chief Executive Officer.
Already a director
Beck has already been a member of the board of directors of BeautyHealth. Generally speaking, most director-turned-CEO appointments occur following a sudden resignation of the outgoing CEO and signal a lack of preparedness on the company’s part to groom internal talent. Directors-turned-executives represent a blend of outsider and insider.
They don’t have the constraints of a pure insider when it comes to leading painful changes or making unpopular decisions, and they have more company knowledge than a pure outsider.
Having been a director, Beck understands the expectations and dynamics of the board and has knowledge of BeautyHealth’s organization, risk-management practices and strategy.
No reason given
In the announcement, BeautyHealth did not explicitly explain the reason for the move.
Precise information regarding Andrew Stanleick’s future plans was not immediately available.
BeautyHealth said: “Andrew Stanleick will depart the Company as President & Chief Executive Officer and relinquish his Board seat, effective November 19, 2023.”
BeautyHealth further said: “Ms. Beck will replace Andrew Stanleick, who will step down from the role of chief executive officer of the Company, effective as of November 19, 2023.”
Share price decline since February 2022
The announcement follows a decline in BeautyHealth Co.’s share price of 75% since February 2022. February 2022 is the month in which Stanleick’s tenure as CEO began.
In the position of CEO since 2022
Andrew Stanleick became CEO of the Company in 2022.
Stanleick will serve in an advisory role with the Company through the end of the year.
Andrew Stanleick has served as the Company’s Chief Executive Officer, President and Director since February 7, 2022.
Prior to joining the Company, Stanleick held senior roles at Coty Inc. (“Coty”), a multi-national beauty company, since August 2017, including serving as its Executive Vice President, Americas and Chief Executive Officer of Kylie Jenner Beauty since March 2020.
From June 2018 to May 2020, Stanleick served as Coty’s Senior Vice President, North America, and from August 2017 to June 2018, he served as its Senior Vice President, Europe.
Prior to joining Coty, Stanleick worked in various roles, including President and Chief Executive Officer of the South East Asia-Pacific and European divisions of Coach Inc., a luxury American fashion company specializing in leather handbags, luggage, and accessories, from January 2013 to April 2016.
He currently serves on the Executive Board of Directors for the Personal Care Products Council and The Fragrance Foundation.
64 words by Andrew Stanleick
In the release announcing his departure as CEO of BeautyHealth Co., Andrew Stanleick received praise, thanks and good wishes.
In announcing his departure, Andrew Stanleick said 64 words.
“I remain an ardent supporter of BeautyHealth”
Andrew Stanleick stated: “It has been an honor to lead BeautyHealth, and I would like to thank Brent and the Board for the opportunity. I leave inspired by the passion of our teams, providers and consumers and the brand-forward vision that Hydrafacial has set out. I believe deeply in the future opportunity of the professional beauty and aesthetics sector – and I remain an ardent supporter of BeautyHealth.”
Push-out Score for Andrew Stanleick’s move determined
The Push-out Score indicates on a scale of 0 to 10 how likely it is that Andrew Stanleick was pushed out or felt pressure to leave his position.
exechange reached out to BeautyHealth and offered the company the opportunity to comment on the score.
Read the full story in the exechange report 47.2023 ($).